CD8A and cancer: The cytotoxic capacity of CD8+ T cells primed by checkpoint inhibition immunotherapy has recently been shown to be mediated through ferroptosis, a pathway of oxidative programmed cell death to which cancer cells appear to be uniquely susceptible (15–20).